Time of acquisition of HCV infection in renal transplant recipients: a major prognostic factor for disease progression

This study aims to identify crucial factors affecting the evolution of liver disease in HCV‐infected renal transplant recipients.

[1]  E. Ok,et al.  The acquisition time of infection: a determinant of the severity of hepatitis C virus‐related liver disease in renal transplant patients , 2009, Clinical transplantation.

[2]  N. Sakamoto,et al.  Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy. , 2008, Transplantation proceedings.

[3]  F. Luan,et al.  Impact of Immunosuppressive Regimen on Survival of Kidney Transplant Recipients With Hepatitis C , 2008, Transplantation.

[4]  A. Hatzakis,et al.  Apoptosis and hepatitis C virus infection in renal transplant recipients. , 2008, American journal of clinical pathology.

[5]  G. Gaffuri,et al.  Cyclosporin in steroid-resistant autoimmune hepatitis and HCV-related liver diseases. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[6]  J. Lake,et al.  Emerging Issues in Hepatitis C Virus‐Positive Liver and Kidney Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  A. Hatzakis,et al.  The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  F. Fabrizi,et al.  Review article: hepatitis C virus and calcineurin inhibition after renal transplantation , 2005, Alimentary pharmacology & therapeutics.

[9]  L. Rostaing,et al.  Natural History of Hepatitis C Virus‐Related Liver Fibrosis After Renal Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  F. Fabrizi,et al.  Hepatitis C Virus Antibody Status and Survival After Renal Transplantation: Meta‐Analysis of Observational Studies , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  M. Ramos-Casals,et al.  Mycophenolate mofetil in patients with hepatitis C virus infection , 2005, Lupus.

[12]  P. Messa,et al.  [Hepatitis C virus and renal transplantation]. , 2004, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.

[13]  A. Hatzakis,et al.  Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection , 2004, Journal of viral hepatitis.

[14]  A. Zekry,et al.  Mechanisms of HCV reinfection and allograft damage after liver transplantation. , 2004, Journal of hepatology.

[15]  J. Hoofnagle,et al.  Hepatitis C and renal disease: an update. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  J. Piette,et al.  Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. , 2002, Gastroenterology.

[17]  M. Olschewski,et al.  Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation , 2002, Clinical transplantation.

[18]  C. Ponticelli,et al.  Hepatitis C virus infection and renal transplantation. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  A. Hatzakis,et al.  Cholestatic syndrome with bile duct damage and loss in renal transplant recipients with HCV infection. , 2001, Liver.

[20]  J. Morales,et al.  Transplantation in the patient with hepatitis C , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[21]  L. Rostaing,et al.  Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil. , 2000, Transplantation.

[22]  A. Hatzakis,et al.  Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  P Coriat,et al.  Impact of hepatitis B and C virus on kidney transplantation outcome , 1999, Hepatology.

[24]  U. Akarca,et al.  Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  L. Rostaing,et al.  Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features. , 1998, Transplantation.

[26]  J. Campistol,et al.  Hepatitis C virus and renal transplantation , 1998, Current opinion in nephrology and hypertension.

[27]  J. Collier,et al.  Hepatitis C viral infection in the immunosuppressed patient , 1998, Hepatology.

[28]  G. Vosnides,et al.  Hepatitis C in renal transplantation. , 1997, Kidney international.

[29]  A. Levey,et al.  Hepatitis C virus infection in dialysis and renal transplantation. , 1997, Kidney international.

[30]  P. Bedossa,et al.  Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.

[31]  G. Ciancio,et al.  A prospective study of hepatitis C virus infection in renal allograft recipients. , 1996, Transplantation.

[32]  A. Levey,et al.  THE IMPACT OF PRETRANSPLANTATION HEPATITIS C INFECTION ON THE OUTCOME OF RENAL TRANSPLANTATION , 1995, Transplantation.

[33]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[34]  A. Lok,et al.  A prospective study of hepatitis C virus infection among renal transplant recipients. , 1993, Gastroenterology.

[35]  S. Xiao,et al.  Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis. , 2008, International journal of clinical and experimental pathology.

[36]  花房 徹.  Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years , 2000 .

[37]  S. Thung,et al.  Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients , 1999, American Journal of Gastroenterology.

[38]  J. Morales.  Hepatitis C and renal transplantation: outcome of patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  Y. Berland,et al.  Hepatitis C virus infection contracted just before kidney transplantation. , 1995, Nephron.

[40]  A. Lok,et al.  Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation. , 1995, Nephron.

[41]  J. Morales,et al.  Does ciclosporin induce clinical remission of dialysis-acquired active chronic hepatitis? , 1989, Nephron.